Recent research discoveries revealed that while the CD1A+CD207+ histiocytes are the hallmark of LCH, other BRAF-mutated peripheral blood mononuclear cell populations (such as NK cells and granulocytes) may contribute to the substantial diversity of LCH clinical manifestations. This evidence concerns the gene CD1A and Langerhans cell histiocytosis.